Xeris Biopharma Director Sells 107,500 Shares at $7.32 Per Share on August 13.

Xeris Biopharma Holdings, Inc. [XERS] recently announced that Director Johnson John has sold 107,500 shares at a price of $7.32 per share on August 13, 2025.

Xeris Biopharma Holdings, Inc. [XERS] recently announced that Director Johnson John sold 107,500 shares of the company's Common Stock on August 13, 2025. The transaction was executed at a weighted average price of $7.3159 per share, totaling $786,459. Following this sale, Johnson directly owns 833,483 shares of the company.

The sale was reported through the SEC Filing Form 4, which is a standard form used by corporate insiders to report transactions in company securities. This filing provides transparency and helps investors make informed decisions.

This transaction follows the recent market trends and the overall performance of Xeris Biopharma Holdings, Inc. As of the current date, the stock price remains steady, reflecting the company's ongoing efforts in biopharmaceutical research and development.

For more details, refer to the SEC filing [1].

References:
[1] https://www.tradingview.com/news/tradingview:4113513c36a72:0-xeris-biopharma-holdings-director-sells-107-500-shares/